Aceclofenac, Paracetamol and Chlorzoxazone Tablets – ALCLEF-MR

By akash midha, 16 September, 2025

Pain associated with muscle stiffness, inflammation, or injuries is one of the most common health concerns today. Patients suffering from back pain, arthritis, cervical spondylitis, or musculoskeletal disorders often require a treatment that provides both pain relief and muscle relaxation. To meet this need, ALCLEF-MR Tablets, a combination of Aceclofenac, Paracetamol, and Chlorzoxazone, offer an effective solution. Manufactured under WHO-GMP certified facilities, ALCLEF-MR ensures safety, efficacy, and reliable results for patients.

Product Overview

ALCLEF-MR Tablets combine three powerful ingredients:

  • Aceclofenac – a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation.

     

  • Paracetamol – an analgesic and antipyretic that helps control fever and enhances pain relief.

     

  • Chlorzoxazone – a muscle relaxant that works on the central nervous system to relieve stiffness and spasms.

     

This triple-action formulation makes ALCLEF-MR highly effective for musculoskeletal pain where both inflammation and muscle spasm are present. The convenient tablet form ensures accurate dosing and ease of administration.

Medical Uses

Doctors prescribe ALCLEF-MR Tablets in a wide range of painful conditions such as:

  • Acute low back pain and muscle stiffness

     

  • Cervical and lumbar spondylitis

     

  • Musculoskeletal pain and spasms

     

  • Arthritis and osteoarthritis with joint inflammation

     

  • Post-traumatic pain after injuries

     

  • Post-surgical stiffness and discomfort

     

By addressing both inflammation and muscle contraction, ALCLEF-MR provides complete relief, making it a trusted option for both acute and chronic musculoskeletal disorders.

Shop Primary Image

Key Features of ALCLEF-MR

Some highlights of this product include:

  • Triple-action therapy – pain relief, fever control, and muscle relaxation

     

  • Effective for acute musculoskeletal conditions

     

  • Helps restore mobility and flexibility

     

  • Patient-friendly oral tablet form

     

  • Reliable results under medical supervision

     

  • Manufactured under WHO-GMP certified standards

     

These features make ALCLEF-MR a widely accepted product among doctors and patients.

Patient Benefits

For patients, ALCLEF-MR offers multiple benefits in a single tablet:

  • Provides quick relief from pain and muscle stiffness

     

  • Reduces swelling, inflammation, and fever

     

  • Improves mobility and flexibility in daily activities

     

  • Supports faster recovery in injuries and post-surgical conditions

     

  • Enhances overall comfort and quality of life

     

  • Convenient dosage ensures better compliance

     

By combining three effective agents, ALCLEF-MR ensures comprehensive relief that single-drug therapies may not achieve.

Business Opportunities

From a business perspective, ALCLEF-MR belongs to a high-demand therapeutic segment. Pain management and musculoskeletal medicines are always needed, making this product highly profitable for pharma businesses.

  • PCD Pharma Franchise – Partners get monopoly rights, promotional support, and strong brand recall.

     

  • Third-Party Manufacturing – Companies can avail customized branding, attractive packaging, and quality production.

     

  • Consistent Demand – Orthopedics, physiotherapists, and general practitioners frequently prescribe such combinations.

     

  • Competitive Pricing – Ensures affordability for patients and profitability for distributors.

     

With its strong market potential, ALCLEF-MR is a smart choice for pharma distributors and franchise holders.

Marketing & Distribution Strategy

A proper marketing strategy ensures the success of ALCLEF-MR in the market:

  • Positioning it as a complete musculoskeletal pain solution

     

  • Targeting orthopedic specialists, physiotherapists, and general physicians

     

  • Highlighting its triple-action benefits in promotional materials

     

  • Using literature, samples, and visual aids to create awareness

     

  • Focusing on urban hospitals and rural clinics to capture both segments

     

  • Leveraging seasonal and lifestyle-related demand for pain management medicines

     

Such a focused approach ensures long-term growth and consistent returns for pharma partners.

Conclusion

ALCLEF-MR Tablets (Aceclofenac, Paracetamol and Chlorzoxazone) are a powerful combination designed to provide complete relief from pain, inflammation, and muscle stiffness. With its triple-action formula, quick results, and high safety standards, it has earned the trust of doctors and patients alike. For pharma businesses, ALCLEF-MR offers an excellent opportunity through PCD Pharma Franchise and third-party manufacturing.

With ALCLEF-MR, both patients and business partners benefit—ensuring better healthcare outcomes and strong market growth in the pain management segment.